Michael Klichinsky is a Co-Founder and Senior VP of Carisma Therapeutics. Michael developed CAR Macrophages during his PhD thesis at the University of Pennsylvania. He earned a Doctor of Pharmacy degree from the University of Sciences in Philadelphia, and a PhD in Pharmacology from the University of Pennsylvania. His research expertise focuses mainly in immunology, synthetic biology, cancer immunotherapy, and translational pharmacology.